Feature Channels:

Article ID: 697580

New and innovative pain treatments to replace opioids will not be discovered unless pain research funding becomes a priority on Capitol Hill. The APS Pain Research Agenda, published in the Journal of Pain in 2014, states “the most direct path to achieving dramatic advances in pain treatment is through substantially increased investment in pain research and education, which would enable the pursuit of an aggressive translational pain-research agenda.”

Article ID: 697551

Philanthropist Bill Gates and the Alzheimer's Drug Discovery Foundation (ADDF) co-founder Leonard Lauder have announced a new initiative, Diagnostics Accelerator, to develop novel biomarkers for the early detection of Alzheimer's disease and related dementias.

Article ID: 697478

On July 18, scientists will be on Capitol Hill to showcase science and discuss the revolutionary opportunities that exists in medical research, due in large part to the federal investment in the National Institutes of Health. Attendees will have the opportunity to engage in hands-on table top experiments. Come experience fun and innovative science and learn about the advances researchers are making to improve health for all Americans.

Article ID: 696200

The American Society of Nephrology (ASN) greatly appreciates the subcommittee’s continued support of the National Institutes of Health (NIH) as a key national priority with an increase of $1.2 billion, or 3.2%, in the FY 2019 Labor-HHS spending bill. ASN is also grateful for the proposed 1.2% increase for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), for a total allocation of $1.9 billion.

Article ID: 695817

The DHS Science and Technology Directorate (S&T) today issued a standing, open invitation to the scientific and technical communities to propose novel ideas to help address DHS’s most significant priorities. They released a newly modernized Long Range Broad Agency Announcement (LRBAA) with significant enhancements to the process.

Article ID: 695761

The $300,000 prize competition called for the design of an early warning system to keep our communities safe by using existing data sources to uncover emerging biothreats.

Article ID: 695191

As in relativity and quantum mechanics, the combined forces of math and physics have shifted many scientific paradigms and shattered human perceptions of reality over the centuries. Now, a $30 million is conjoining theoretical mathematics and biology to unlock mysteries of life.

Article ID: 695132

The search is on for policy and technology innovation proposals with the potential to foster access to and support for a thriving middle class in Utah — and the best ideas may be eligible for up to $1 million in funding.

Article ID: 693854

NeuroVision Imaging Inc. has announced a Series C financing round of $15 million with an initial close of $11.2 million. The round is led by Wildcat Capital Management with funding from several new investment groups. The financing provides support for NeuroVision as it seeks validation and regulatory approval for its breakthrough, low-cost, noninvasive, eye imaging system for measuring retinal autofluorescence that can detect amyloid beta (Aβ) plaque in the eye.

Article ID: 693622

A small number of scientists stand at the top of their fields, commanding the lion’s share of research funding, awards, citations, and prestigious academic appointments. Are they better and smarter than their peers—or did they luck out with early career success?